Key Takeaways

• The FDA held a panel in December 2025 to review UV disinfection devices used in hospitals.
• UV light only cleans what it can directly see. Shadows, tubing, and fabric go untreated.
• There is no shared standard for testing how well these devices work.
• Very few UV devices hold FDA authorization, and none are classified for reducing HAIs.

According to the FDA, UV disinfection has significant limits. It only cleans surfaces it can directly see, there’s no shared way to test how well it works, and very few devices meet the agency’s bar for hospital use.

Hospitals have leaned on UV-C devices for years to help disinfect patient rooms, with a significant surge in usage during the pandemic. However, a recent FDA panel meeting raised questions about how well UV disinfection actually works, and how much of the technology is still unproven.

On December 10, 2025, the FDA’s General Hospital and Personal Use Devices Panel met to discuss germicidal UV (GUV) devices. This wasn’t a review of one product. Rather, it was a broader look at the whole category, and was held to meet a federal requirement tied to pandemic preparedness.

We’ve written before about aging UV-C devices that are still running in hospitals today, and about the gaps in FDA and EPA approval for these systems. This panel meeting confirmed a lot of limitations that are detailed in various studies. Here’s what the FDA itself had to say.

UV Only Treats What It Can See

The FDA’s executive summary is direct about this limitation. UV light only reaches “directly illuminated surfaces,” which means anything blocked from view goes untreated. This includes shadowed corners, the underside of equipment, and anything tucked behind furniture.

The agency also confirmed that UV “does not penetrate lumens or porous materials.” So tubing, fabric, and other everyday hospital surfaces are out of reach for UV light. We’ve covered this shadowing problem before in our post on common UV shortcomings.

A study conducted by researchers at the University of Arizona put this to the test. Surfaces directly in a leading UV tower’s line of sight reached a mean Log Reduction of 1.32. Surfaces that were shadowed or farther away only reached a mean Log Reduction of 0.72, illustrating a significant gap.

UV Works Well … in an Empty Room

For UV devices marketed as whole-room disinfection tools, the panel said there are “significant challenges due to variability in room configurations.” That means a room full of medical equipment and furniture disinfects very differently than an empty test room. In reality, of course, real hospital rooms are rarely empty or identical.

The FDA also notes that UV can damage the equipment it’s meant to protect, stating that  UV exposure “has been shown to result in the degradation of some device components, especially plastics, rubber and fabrics, over time.” 

The Missing Standard for Testing UV Devices

According to the FDA, there is currently “no universally adopted test method” for measuring how well UV disinfection actually performs. Most existing test standards were built for liquid disinfectants, not light-based technology. Without a shared way to measure results, the agency is left relying on studies designed by the manufacturers themselves, which the FDA says “can vary in rigor and clinical relevance.”

This isn’t just a regulatory concern. A separate peer-reviewed study of UV-C research reached the same conclusion, pointing to a “lack of a uniform standard” among the many UV devices sold today. 

Only A Few UV Devices Meet the FDA’s Bar

Under current FDA rules, whole-room microbial reduction devices only received their first classification in 2023. As of the panel meeting, only two products have been authorized under that category. A related classification for UV disinfection chambers only appeared in 2024, and only one product holds that authorization today.

The panel also discussed devices marketed for reducing HAIs, a major concern for hospitals everywhere. Right now, the FDA has not classified any GUV device for that specific use. Any claim that a UV device reduces or prevents these conditions goes beyond what the agency has actually reviewed and approved.

Questioning the Effectiveness of UV

The FDA pointed out that germs can partly recover after UV exposure. At inadequate doses, the agency notes that “some microbes may survive, repair damage, and potentially regain viability” through a process called photoreactivation.

Independent research backs this up. A peer-reviewed study found that up to 60% of the disinfection UV achieved was undone once treated microorganisms had a chance to repair themselves. So a room that has been disinfected with UV can have living germs on its surfaces a few hours later.

The FDA’s framework sorts disinfection outcomes into tiers: low-, intermediate-, or high-level, based on how much microbial load is actually reduced. Independent research places UV squarely in the lower tier. That same peer-reviewed study concluded the technology “should currently be considered for low-level rather than high-level disinfection.”

The University of Arizona study measured this shortfall directly. Testing a leading UV tower against a common hospital bacteria, researchers found a mean Log Reduction of just 1.02, or about a 90.45% reduction. The EPA requires a Log Reduction of 4.0 to call something a hospital-grade disinfectant. 

Where This Leaves Hospitals

The FDA panel made it clear that UV alone leaves real gaps in coverage, in consistent testing, and in regulatory backing for the biggest claims. If your facility is still relying on an aging or unproven UV system, it may be worth asking harder questions about what it’s actually doing, and what it isn’t.

We put UV head to head against fogging technology in our post on UV vs. foggers if you want to see how the two approaches compare on coverage, cost, and effectiveness.

Nevoa’s Nimbus and Stratus systems use EPA-registered Microburst solution to reach every environmental surface in a room, not just the ones in direct line of sight. Reach out to Nevoa today to learn about a surface disinfection approach built to close the gaps UV leaves behind.

FAQs

Can I trade in my old UV system for credit toward Nevoa’s technology?

Yes. Nevoa offers a trade-in program for facilities upgrading from UV disinfection. You can trade in your existing UV system for credit toward Nimbus. 

What are the main limits of UV disinfection, according to the FDA?
UV light only reaches surfaces it can directly see. It does not reach shadowed areas, tubing, or fabric. Room layout and equipment placement can block it further.

Are UV disinfection devices FDA approved?
No. UV devices go through FDA authorization or clearance, not approval. As of the panel meeting, only two products hold authorization for whole-room microbial reduction, and one holds authorization for UV disinfection chambers.

Is there a standard test for measuring UV performance?
No. The FDA says there is no universally adopted test method for these devices. Most existing standards were built for liquid disinfectants, not light.

Can bacteria recover after UV exposure?
Yes. This is called photoreactivation. At low doses, some microbes can survive, repair themselves, and become active again. One independent study found up to 60% of UV disinfection was undone this way.

How does fogging compare to UV for surface disinfection?
Fogging with Nevoa’s EPA-registered Microburst solution reaches surfaces regardless of line of sight, including shadowed spots and areas behind equipment. UV only treats what it can directly see.